NanoRepro Stock

NanoRepro Employees 2024

NanoRepro Employees

13

Ticker

NN6.DE

ISIN

DE0006577109

WKN

657710

In 2024, NanoRepro employed 13 people, a 0% change from the 13 number of employees in the previous year.

NanoRepro Aktienanalyse

What does NanoRepro do?

The Nanorepro AG was founded in 1998 in Marburg an der Lahn and has since developed into a leading company in the development and production of diagnostic rapid tests and self-tests. The company has been listed on the Frankfurt Stock Exchange since 2006 and has its headquarters in the university city of Marburg. Nanorepro's business model focuses on the production and distribution of innovative, reliable, and easy-to-use self-tests for the medical field. The company concentrates on the practical application of the tests - they should be simple, fast, and user-friendly. Nanorepro's core competence lies in the design, production, and distribution of rapid tests and self-tests for the medical field. The company relies on close cooperation with other companies and research institutions to continuously improve the tests and develop new products. Nanorepro focuses on various areas, including the manufacturing of rapid tests and self-tests for the diagnosis of infectious diseases. In addition, the company also offers tests to check pregnancy status or determine ovulation. Nanorepro's range of products also includes self-tests for the early detection of diseases such as diabetes. With its wide range of products, the company is able to address a large customer base and achieve a positive market position. One key product of Nanorepro is the early pregnancy test. This product is easy to handle and allows women to quickly and safely determine if they are pregnant or not. Nanorepro also offers an ovulation test to help women determine the timing of ovulation. Another test offered by the company is the Lyme borreliosis self-test, which allows for the detection of antibodies to Lyme borreliosis. Nanorepro also offers numerous tests for diagnosing infectious diseases. These include tests that can diagnose bacterial or viral infections such as streptococcal infections or hepatitis B and C. The tests are highly accurate and reliable, enabling quick diagnosis and treatment. Another area in which Nanorepro is expanding is the development of self-tests for the early detection of cancer. For this purpose, the company works closely with scientific and research institutions to continuously improve the tests and make them even more precise and reliable. Nanorepro places a strong emphasis on quality control and safety in the production of the tests. The products are CE-certified, ensuring high quality and safety for the user. In addition, the company has been certified according to the standards of the International Quality Management System ISO 13485, guaranteeing a high standard in the production and marketing of medical devices. Overall, Nanorepro AG has established itself as a leading company in the field of rapid tests and self-tests. With its wide range of products and constant willingness to innovate, the company is able to quickly and effectively respond to the requirements of customers and partners. The company's extensive experience in the field of medical diagnostics contributes to Nanorepro being perceived as a reliable partner in medical technology. NanoRepro ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining NanoRepro's Employee Base

NanoRepro's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding NanoRepro's operational capacity and future potential.

Year-to-Year Comparison

Assessing NanoRepro's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

NanoRepro's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in NanoRepro’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about NanoRepro stock

How many employees does NanoRepro have this year?

NanoRepro has 13 undefined employees this year.

How many employees did NanoRepro have compared to the previous year?

Compared to the previous year, NanoRepro had 0% more employees.

What impact did the number of employees have on the company NanoRepro?

The number of employees has a direct impact on the efficiency and productivity of NanoRepro. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of NanoRepro?

The number of employees can also have an impact on investors of NanoRepro, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of NanoRepro affect the company?

An increase in equity of NanoRepro can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in NanoRepro's equity affect the company?

A reduction in equity of NanoRepro can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of NanoRepro?

Some factors that can influence the equity of NanoRepro include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of NanoRepro so important for investors?

The equity of NanoRepro is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at NanoRepro influence the company?

The number of employees at NanoRepro can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at NanoRepro evolved in recent years?

In recent years, the number of employees at NanoRepro has changed by 0.

How many employees does NanoRepro currently have?

NanoRepro currently has 13 undefined employees.

Why is the number of employees important for investors of NanoRepro?

The number of employees is important for investors of NanoRepro as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can NanoRepro take to change the number of employees?

To change the number of employees, NanoRepro can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does NanoRepro pay?

Over the past 12 months, NanoRepro paid a dividend of 0.5 EUR . This corresponds to a dividend yield of about 27.78 %. For the coming 12 months, NanoRepro is expected to pay a dividend of 0.5 EUR.

What is the dividend yield of NanoRepro?

The current dividend yield of NanoRepro is 27.78 %.

When does NanoRepro pay dividends?

NanoRepro pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of NanoRepro?

NanoRepro paid dividends every year for the past 1 years.

What is the dividend of NanoRepro?

For the upcoming 12 months, dividends amounting to 0.5 EUR are expected. This corresponds to a dividend yield of 27.78 %.

In which sector is NanoRepro located?

NanoRepro is assigned to the 'Health' sector.

Wann musste ich die Aktien von NanoRepro kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of NanoRepro from 6/20/2023 amounting to 0.15 EUR, you needed to have the stock in your portfolio before the ex-date on 6/16/2023.

When did NanoRepro pay the last dividend?

The last dividend was paid out on 6/20/2023.

What was the dividend of NanoRepro in the year 2023?

In the year 2023, NanoRepro distributed 0 EUR as dividends.

In which currency does NanoRepro pay out the dividend?

The dividends of NanoRepro are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The NanoRepro stock can be added to a savings plan with the following providers: ING

Andere Kennzahlen von NanoRepro

Our stock analysis for NanoRepro Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NanoRepro Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.